Editorial: HIV and Antiretroviral Drugs: Current Status and New Challenges

E-ISSN： 1873-4286|23|18|2551-2551

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.18, 2017-07, pp. : 2551-2551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiretroviral Drugs in Pediatric HIV-Infected Patients: Pharmacokinetic and Practical Challenges

By Phelps B. Ryan Rakhmanina Natella

Pediatric Drugs, Vol. 13, Iss. 3, 2011-06 ,pp. : 175-192

Adis International

Access to resources Recommend Favorite

Current status of antiretroviral therapies

By Temesgen Zelalem

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 8, 2001-08 ,pp. : 1239-1246

Informa Healthcare

Access to resources Recommend Favorite

Current status of antiretroviral therapy

By Temesgen Zelalem Warnke David Kasten Mary J

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1541-1554

Informa Healthcare

Access to resources Recommend Favorite

Antimalarial drugs: current status and new developments

By Rathore Dharmendar McCutchan Thomas F Sullivan Margery Kumar Sanjai

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 7, 2005-07 ,pp. : 871-883

Informa Healthcare

Access to resources Recommend Favorite

The Current Status and Challenges in the Development of Fusion Inhibitors as Therapeutics for HIV-1 Infection

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1810-1817

Bentham Science Publishers

Access to resources Recommend Favorite